초록 열기/닫기 버튼
Background: Posterior tibial tendinopathy (PTT) is a degenerative condition impacting the posterior tibial tendon, often leading to pain, impaired mobility, and potential deformities like flatfoot. While traditional therapies such as physical therapy, orthotics, and NSAIDs are common, minimally invasive techniques like ultrasound-guided hydrodissection are emerging as promising alternatives. Objectives: This study aims to evaluate the efficacy and safety of ultrasound-guided hydrodissection in treating posterior tibial tendinopathy, offering a non-steroidal, minimally invasive treatment option. Methods: Three patients diagnosed with posterior tibial tendinopathy underwent ultrasound guided hydrodissection using 5% dextrose solution. The procedure involved injecting the solution between the tendon and sheath to break adhesions and improve gliding function. Pain levels were assessed using the Numerical Rating Scale (NRS), and functional outcomes were measured via clinical tests like plantar flexion, inversion, and the single-heel rise test. Results: All patients reported significant pain reduction, with NRS scores dropping from 6–7 to 0. Functional improvements were noted, with restored mobility and resolution of symptoms. No adverse effects were observed during or after the treatments, which required only 2–3 sessions for full recovery. Conclusion: Ultrasound-guided hydrodissection is an effective and safe treatment for posterior tibial tendinopathy. This minimally invasive approach addresses adhesions and improves tendon function, providing a viable alternative to steroid injections or surgical interventions. Future studies with larger samples and standardized protocols are recommended to validate these findings.
Background: Posterior tibial tendinopathy (PTT) is a degenerative condition impacting the posterior tibial tendon, often leading to pain, impaired mobility, and potential deformities like flatfoot. While traditional therapies such as physical therapy, orthotics, and NSAIDs are common, minimally invasive techniques like ultrasound-guided hydrodissection are emerging as promising alternatives. Objectives: This study aims to evaluate the efficacy and safety of ultrasound-guided hydrodissection in treating posterior tibial tendinopathy, offering a non-steroidal, minimally invasive treatment option. Methods: Three patients diagnosed with posterior tibial tendinopathy underwent ultrasound guided hydrodissection using 5% dextrose solution. The procedure involved injecting the solution between the tendon and sheath to break adhesions and improve gliding function. Pain levels were assessed using the Numerical Rating Scale (NRS), and functional outcomes were measured via clinical tests like plantar flexion, inversion, and the single-heel rise test. Results: All patients reported significant pain reduction, with NRS scores dropping from 6–7 to 0. Functional improvements were noted, with restored mobility and resolution of symptoms. No adverse effects were observed during or after the treatments, which required only 2–3 sessions for full recovery. Conclusion: Ultrasound-guided hydrodissection is an effective and safe treatment for posterior tibial tendinopathy. This minimally invasive approach addresses adhesions and improves tendon function, providing a viable alternative to steroid injections or surgical interventions. Future studies with larger samples and standardized protocols are recommended to validate these findings.